Quantcast

Latest Regulus Therapeutics Inc. Stories

2014-05-08 16:27:14

- 'Clinical Map Initiative' On Track; Advanced RG-101 and RG-012, Expect to Nominate Third microRNA Clinical Candidate by YE 2014 - LA JOLLA, Calif., May 8, 2014 /PRNewswire/ --

2014-05-01 16:32:43

LA JOLLA, Calif., May 1, 2014 /PRNewswire/ -- Regulus Therapeutics Inc.

2014-04-30 16:30:42

LA JOLLA, Calif., April 30, 2014 /PRNewswire/ -- Regulus Therapeutics Inc.

2014-04-07 08:30:29

- Data Advances microRNA Oncology Portfolio - LA JOLLA, Calif., April 7, 2014 /PRNewswire/ -- Regulus Therapeutics Inc.

2014-04-04 16:23:43

LA JOLLA, Calif., April 4, 2014 /PRNewswire/ -- Regulus Therapeutics Inc.

2014-03-25 08:29:32

LA JOLLA, Calif., March 25, 2014 /PRNewswire/ -- Regulus Therapeutics Inc.

2014-03-05 08:28:56

- Study Designed to Demonstrate Human Proof-of-Concept Results by YE 2014 - LA JOLLA, Calif., March 5, 2014 /PRNewswire/ -- Regulus Therapeutics Inc.

2014-02-27 16:28:10

- Achieved All Goals on 'Road to the Clinic'; Launched 'Clinical Map Initiative'- LA JOLLA, Calif., Feb.

2014-02-26 16:29:07

LA JOLLA, Calif., Feb. 26, 2014 /PRNewswire/ -- Regulus Therapeutics Inc.

2014-02-20 16:25:50

LA JOLLA, Calif., Feb. 20, 2014 /PRNewswire/ -- Regulus Therapeutics Inc.


Word of the Day
deuteragonist
  • A person in a secondary role, specifically the second most important character (after the protagonist).
The word 'deuteragonist' comes from a Greek word meaning 'an actor of second-class parts'.
Related